ECO Animal Health
Ticker: EAH Exchange: AIM www.ecoanimalhealthgroupplc.com/

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

Milestone poultry vaccine submission

Eco Animal Health reports that it has submitted a key Market Authorisation Application (MAA) to the European Medicines Agency (EMA), with supporting documentation, for its ECOVAXXIN®MS, Mycoplasma synoviae, vaccine. This represents an important step towards commercialisation for ECOVAXXIN®MS, one of nine major new vaccines under development. This is a process which we expect to be replicated and as CEO David Hallas notes, this “represents a pivotal moment for ECO”. Significantly, the Group continues to submit technical data to the US Department of Agriculture (USDA) for both ECOVAXXIN® Mycoplasma synoviae and ECOVAXXIN® Mycoplasma gallisepticum (MG), and expects to gain marketing approval in the US, subject to dossier review, at about the same time as in Europe.

 
Download as a PDF file
26810392321 - eco-animal-health
Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Register For Updates